FDA approves updated labeling for anticoagulant

The Food and Drug Administration has approved updated labeling for Coumadin, a widely used blood-thinning drug. The agency expects makers of warfarin, the generic version of Coumadin, to add similar information to their product labeling.

The labeling updates are based on recent studies that found people respond to the drug differently based in part on whether they have variations of certain genes. The new labeling highlights that genetic testing may help optimize the use of warfarin and lower the risk of bleeding complications from the drug.

[ via AHA News Now ]